Get started
Author

Mustafa Gürbüz

Observed names: G. Mustafa, Gurbuz, Mustafa, GÜRBÜZ, MUSTAFA, Gürbüz, Mustafa, M Kezban Gürbüz, M. Gürbüz, Mustafa Gurbuz, Mustafa GÜRBÜZ
Institution: Başkent University
ORCID: 0000-0001-7680-4142
Observed ORCID: 0000-0001-7680-4142
OpenAlex ID: A5062083937
Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group
2022 · Mustafa Gürbüz, Yasin Kutlu, et al. · Journal of Cancer Research and Clinical Oncology · 13
Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group
2021 · Mustafa Gürbüz, Erman Akkuş, et al. · Journal of Gastrointestinal Cancer · 10
Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer
2025 · Yasin Sezgin, Oğur Karhan, et al. · Scientific Reports · 9
PDF
Worse patient–physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG)
2020 · Ali Alkan, Arzu Yaşar, et al. · European Journal of Cancer Care · 9
Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study
2021 · Burak Bilgin, Mehmet Ali Nahit Sendur, et al. · Journal of Cancer Research and Clinical Oncology · 7
Crizotinib efficacy and safety in patients with advanced NSCLC harboring MET alterations: A real-life data of Turkish Oncology Group
2022 · Mustafa Gürbüz, Saadettin Kiliçkap, et al. · Medicine · 6
Efficacy and tolerability of vismodegib treatment in locally advanced and metastatic basal cell carcinoma: Retrospective real‐life data
2021 · Mustafa Gürbüz, İzzet Doğan, et al. · Dermatologic Therapy · 6
PDF
Topical aloe vera for the treatment of cetuximab-related acneiform rash in colorectal cancer: A case report
2020 · Mustafa Gürbüz, Erman Akkuş, et al. · Journal of Oncology Pharmacy Practice · 6
Prognostic value of inflammatory-nutritional indexes and HALP score in advanced stage NSCLC treated with first-line TKI
2025 · Ali Ogul, Ali Alper Solmaz, et al. · Biomarkers in Medicine · 5
PDF
BRCA 1/BRCA 2 Pathogenic/Likely Pathogenic Variant Patients with Breast, Ovarian, and Other Cancers
2022 · K. Osman, K. Ahmet, et al. · Balkan Journal of Medical Genetics · 5
PDF
The frequency and prognostic significance of ABO/Rh blood groups in male breast cancer patients: A multicenter study
2022 · Izzet Dogan, Murat Ayhan, et al. · Medicine · 5
Enzalutamide versus Abiraterone Acetate as first-line treatment of castration resistant metastatic prostate cancer in geriatric (≥75) patients
2021 · Ali Alkan, Zeynep Gülsüm Güç, et al. · Journal of Men s Health · 5
Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer
2020 · Mustafa Gürbüz, Erman Akkuş, et al. · Tumori Journal · 5
Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey.
2020 · Muhammet Bekir Hacioglu, Osman Kostek, et al. · PubMed · 5
The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study
2021 · Mutlu Hizal, Burak Bilgin, et al. · Journal of Cancer Research and Clinical Oncology · 4
PDF
Evaluation of factors predicting pathologic complete response in locally advanced HER2 positive breast cancer treated with neoadjuvant pertuzumab, trastuzumab and chemotherapy; Real life data.
2021 · Ozturk Ates, O Berna Oksuzoglu, et al. · PubMed · 4
Real-World Outcomes in BRAF-Mutant Non-small Cell Lung Cancer: A Multicenter Analysis From the Turkish Oncology Group
2025 · Tuğba Akın Telli, Ali Murat Tatlı, et al. · Clinical Lung Cancer · 3
Importance of hematological and inflammatory markers in the localization of gastric cancer
2025 · Süleyman Dolu, Mehmet B Cengiz, et al. · World Journal of Gastrointestinal Oncology · 3
The impact of carboplatin on pathologic complete response and survival based on HER2 low and HER2 zero status in triple negative breast cancer patients receiving neoadjuvant chemotherapy: a multicenter real-world analysis
2025 · Sedat Yıldırım, Tugba Başoğlu, et al. · BMC Cancer · 2
PDF
The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing
2024 · Osman Köstek, Ahmet Demirel, et al. · Journal of Chemotherapy · 2
Seasonal Influenza and Pneumococcal Vaccination Rates Among Patients with Cancer in COVID-19 Pandemic: A Cross-Sectional Study
2021 · Emre YEKEDÜZ, Elif Berna KÖKSOY, et al. · Journal of Oncological Sciences · 2
PDF
[A case of maxillary sinus mucocele with orbital involvement].
2007 · Hamdi Cakli, M Kezban Gürbüz, et al. · PubMed · 2
Prognostic Value of Metabolic Tumor Volume and Heterogeneity Index in Diffuse Large B-Cell Lymphoma.
2025 · Ali Alper Solmaz, Ilhan Birsenogul, et al. · PubMed Central · 1
PDF
The Relationship Between Illness Perception and Coping Strategies in Cancer Patients Undergoing Chemotherapy
2024 · Yusufcan Yılmaz, Mustafa Gürbüz, et al. · Journal of Ankara University Faculty of Medicine · 1
PDF
Distributions and prognostic effects of ABO/Rh blood groups in patients with HER2/neu positive gastric and gastroesophageal junction cancer
2023 · Izzet Dogan, Mustafa Gurbuz, et al. · Journal of Cancer Research and Therapeutics · 1
Works count: 54
Citation count: 125
H-index: 6
I10-index: 2
Year
Topic
Type